{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:21:32Z","timestamp":1790821292233,"version":"4.1.0"},"reference-count":31,"publisher":"Galenos Yayinevi","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["dir"],"published-print":{"date-parts":[[2024,5,13]]},"DOI":"10.4274\/dir.2024.242697","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:36:41Z","timestamp":1715596601000},"page":"0-0","source":"Crossref","is-referenced-by-count":4,"title":["Assessing hepatic steatosis by magnetic resonance in potential living liver donors"],"prefix":"10.4274","volume":"0","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8873-3476","authenticated-orcid":false,"given":"Di\u011fdem","family":"Kuru \u00d6z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-7965","authenticated-orcid":false,"given":"Zeynep","family":"Ellik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8638-8688","authenticated-orcid":false,"given":"Ay\u015fegu\u0308l","family":"Gu\u0308rsoy \u00c7oruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5453-8621","authenticated-orcid":false,"given":"Mehmet","family":"Ad\u0131gu\u0308zel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-1467","authenticated-orcid":false,"given":"Mesut","family":"Gu\u0308mu\u0308\u015fsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8868-1362","authenticated-orcid":false,"given":"Saba","family":"Kiremitci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-9540","authenticated-orcid":false,"given":"Onur Elvan","family":"K\u0131r\u0131mker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5663-0683","authenticated-orcid":false,"given":"Hale","family":"G\u00f6kcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3324-248X","authenticated-orcid":false,"given":"Atilla Halil","family":"Elhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6246-1123","authenticated-orcid":false,"given":"Deniz","family":"Balc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-1419","authenticated-orcid":false,"given":"Berna","family":"Sava\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-5428","authenticated-orcid":false,"given":"Ay\u015fe","family":"Erden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8840-5472","authenticated-orcid":false,"given":"Ramazan","family":"\u0130dilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2023:101133. [CrossRef]","DOI":"10.1097\/HEP.0000000000000696"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;6473-6484. [CrossRef]","DOI":"10.1002\/hep.28431"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547-555. [CrossRef]","DOI":"10.1053\/j.gastro.2014.11.039"},{"key":"ref3","unstructured":"4. Yilmaz Y, Yilmaz N, Ates F, et al. The prevalence of metabolic-associated fatty liver disease in the Turkish population: a multicenter study. Hepatol Forum. 202121;2:37-42. [CrossRef]"},{"key":"ref4","unstructured":"5. Yilmaz S, Kayaalp C, Ara C, et al. Single-center analysis of the first 304 living-donor liver transplantations in 3 years. Hepatogastroenterology. 2013;60:1105-1109. [CrossRef]"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Chen CL, Fan ST, Lee SG, Makuuchi M, Tanaka K. Living-donor liver transplantation: 12 years of experience in Asia. Transplantation. 2003;75(3 Suppl):6-11. [CrossRef]","DOI":"10.1097\/01.TP.0000046533.93621.C7"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Cheng YF, Chen CL, Lai CY, et al. Assessment of donor fatty livers for liver transplantation. Transplantation. 2001;71:1221-1225. [CrossRef]","DOI":"10.1097\/00007890-200105150-00007"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Perez-Daga JA, Santoyo J, Su\u00e1rez MA, et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transplant Proc. 2006;38:2468-2470. [CrossRef]","DOI":"10.1016\/j.transproceed.2006.08.077"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Sharma A, Ashworth A, Behnke M, Cotterell A, Posner M, Fisher RA. Donor selection for adult-to-adult living donor liver transplantation: well begun is half done. Transplantation. 2013;95:501-506. [CrossRef]","DOI":"10.1097\/TP.0b013e318274aba1"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Trotter JF, Campsen J, Bak T, et al. Outcomes of donor evaluations for adult\u2010to\u2010adult right hepatic lobe living donor liver transplantation. Am J Transplant. 2006;6:1882-1889. [CrossRef]","DOI":"10.1111\/j.1600-6143.2006.01322.x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Gallegos-Orozco JF, Silva AC, Batheja MJ, et al. Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging. 2015;40:795-802. [CrossRef]","DOI":"10.1007\/s00261-014-0310-y"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Kim SH, Lee JM, Han JK, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings. Radiology. 2006;240:116-129. [CrossRef]","DOI":"10.1148\/radiol.2393042218"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898-1906. [CrossRef]","DOI":"10.1053\/j.gastro.2005.03.084"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int. 2008;28:705-712. [CrossRef]","DOI":"10.1111\/j.1478-3231.2008.01691.x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Hwang I, Lee JM, Lee KB, et al. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. Radiology. 2014;271:730-738. [CrossRef]","DOI":"10.1148\/radiol.14130863"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020;69:1343-4352. [CrossRef]","DOI":"10.1136\/gutjnl-2018-317593"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Hsu C, Caussy C, Imajo K, et al. Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol. 2019;17:630-637. [CrossRef]","DOI":"10.1016\/j.cgh.2018.05.059"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Cui J, Heba E, Hernandez C, et al. Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study. Hepatology. 2016;63:453-461. [CrossRef]","DOI":"10.1002\/hep.28337"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598-607.e2. [CrossRef]","DOI":"10.1053\/j.gastro.2016.10.026"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Yokoo T, Serai SD, Pirasteh A, et al. Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology. 2018;286:486-498. [CrossRef]","DOI":"10.1148\/radiol.2017170550"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Rastogi R, Gupta S, Garg B, Vohra S, Wadhawan M, Rastogi H. Comparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors. Indian J Radiol Imaging. 2016;26:5-14. [CrossRef]","DOI":"10.4103\/0971-3026.178281"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Idilman IS, Aniktar H, Idilman R, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013;267:767-775. [CrossRef]","DOI":"10.1148\/radiol.13121360"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Brunt EM, Kleiner DE, Carpenter DH, et al. NAFLD: reporting histologic findings in clinical practice. Hepatology. 2021;73:2028-2038. [CrossRef]","DOI":"10.1002\/hep.31599"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013;267:422-431. [CrossRef]","DOI":"10.1148\/radiol.12120896"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Chiang HJ, Chang WP, Chiang HW, et al. Magnetic resonance spectroscopy in living-donor liver transplantation. Transplant Proc. 2016;48:1003-1006. [CrossRef]","DOI":"10.1016\/j.transproceed.2015.10.068"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Chaudhary A, Sood G, Kumar N, et al. Validation of accuracy of non-invasive imaging methods (magnetic resonance imaging (MRI) fat fraction calculation and computed tomography (CT) liver attenuation index) for hepatic graft fat quantification in living liver transplant donors. Ann Transplant. 2021;26:e933801. [CrossRef]","DOI":"10.12659\/AOT.933801"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Zheng D, Guo Z, Schroder PM, et al. Accuracy of MR imaging and MR spectroscopy for detection and quantification of hepatic steatosis in living liver donors: a meta-analysis. Radiology. 2017;282:92-102. [CrossRef]","DOI":"10.1148\/radiol.2016152571"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Satkunasingham J, Nik HH, Fischer S, et al. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors? Liver Transpl. 2018;24:470-477. [CrossRef]","DOI":"10.1002\/lt.24965"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Idilman IS, Keskin O, Celik A, et al. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiol. 2016;57:271-278. [CrossRef]","DOI":"10.1177\/0284185115580488"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Zhuang RH, Weinstock AK, Ganesh S, et al. Characterization of hepatic steatosis using controlled attenuation parameter and MRI-derived proton density fat fraction in living donor liver transplantation. Clin Transplant. 2022;36:e14786. [CrossRef]","DOI":"10.1111\/ctr.14786"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Ferraioli G, Maiocchi L, Savietto G, et al. Performance of the attenuation imaging technology in the detection of liver steatosis. J Ultrasound Med. 2021;40:1325-1332. [CrossRef]","DOI":"10.1002\/jum.15512"}],"container-title":["Diagnostic and Interventional Radiology"],"original-title":[],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T08:19:31Z","timestamp":1738311571000},"score":1,"resource":{"primary":{"URL":"https:\/\/dirjournal.org\/articles\/doi\/dir.2024.242697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":31,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2024,5,13]]},"published-print":{"date-parts":[[2024,5,13]]}},"URL":"https:\/\/doi.org\/10.4274\/dir.2024.242697","relation":{},"ISSN":["1305-3825","1305-3612"],"issn-type":[{"value":"1305-3825","type":"print"},{"value":"1305-3612","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]}}}